ATE231392T1 - Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung - Google Patents

Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung

Info

Publication number
ATE231392T1
ATE231392T1 AT00910723T AT00910723T ATE231392T1 AT E231392 T1 ATE231392 T1 AT E231392T1 AT 00910723 T AT00910723 T AT 00910723T AT 00910723 T AT00910723 T AT 00910723T AT E231392 T1 ATE231392 T1 AT E231392T1
Authority
AT
Austria
Prior art keywords
betahistine
controlled release
containing formulation
formulation
release
Prior art date
Application number
AT00910723T
Other languages
English (en)
Inventor
Flavio Fabiani
Enrico Frimonti
Mauro Valenti
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Application granted granted Critical
Publication of ATE231392T1 publication Critical patent/ATE231392T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT00910723T 1999-03-05 2000-02-28 Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung ATE231392T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (1)

Publication Number Publication Date
ATE231392T1 true ATE231392T1 (de) 2003-02-15

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00910723T ATE231392T1 (de) 1999-03-05 2000-02-28 Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung

Country Status (37)

Country Link
EP (1) EP1158963B1 (de)
JP (1) JP2002538197A (de)
KR (1) KR20010102498A (de)
CN (1) CN1165295C (de)
AR (1) AR029154A1 (de)
AT (1) ATE231392T1 (de)
AU (1) AU762532B2 (de)
BG (1) BG105807A (de)
BR (1) BR0008739A (de)
CA (1) CA2364226A1 (de)
CO (1) CO5170438A1 (de)
CZ (1) CZ299510B6 (de)
DE (1) DE60001266T2 (de)
DK (1) DK1158963T3 (de)
EE (1) EE200100453A (de)
ES (1) ES2189739T3 (de)
GE (1) GEP20033078B (de)
HK (1) HK1042246B (de)
HR (1) HRP20010650A2 (de)
HU (1) HUP0200243A2 (de)
ID (1) ID30127A (de)
IL (1) IL145263A0 (de)
IT (1) IT1309591B1 (de)
MX (1) MXPA01008893A (de)
NO (1) NO319135B1 (de)
NZ (1) NZ513949A (de)
PE (1) PE20001547A1 (de)
PL (1) PL196290B1 (de)
PT (1) PT1158963E (de)
RU (1) RU2248791C2 (de)
SI (1) SI1158963T1 (de)
SK (1) SK284584B6 (de)
TR (1) TR200102566T2 (de)
UA (1) UA65652C2 (de)
WO (1) WO2000053162A1 (de)
YU (1) YU64001A (de)
ZA (1) ZA200107318B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2509259A1 (en) * 2003-01-23 2004-08-05 Amorepacific Corporation Sustained-release preparations and method for producing the same
ES2306827T3 (es) * 2003-07-04 2008-11-16 Farmaceutici Formenti S.P.A. Composiciones de betahistina de liberacion controlada.
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
KR20060134041A (ko) 2004-04-22 2006-12-27 모르 리서치 애플리케이션즈 리미티드 음식물 섭취 관리 방법
JP2008507508A (ja) * 2004-07-22 2008-03-13 株式會社アモーレパシフィック トピラメート徐放性製剤及びその製造方法
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
NZ589742A (en) 2008-05-27 2012-06-29 Univ Melbourne Methods of treating mammals with eustachian tube dysfunctions with betahistine
EP2314296A1 (de) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Betahistin Tabletten
EP2491930A1 (de) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmazeutische Kombination von Betahistin mit Trimetazidin
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
DK3431078T3 (da) * 2017-07-20 2021-04-19 Intas Pharmaceuticals Ltd Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
JP2002511777A (ja) * 1996-10-28 2002-04-16 ゼネラル ミルズ，インコーポレイテッド 調放性粒子の埋包およびカプセル化

Also Published As

Publication number Publication date
IT1309591B1 (it) 2002-01-24
YU64001A (sh) 2004-05-12
CZ299510B6 (cs) 2008-08-20
SK284584B6 (sk) 2005-07-01
CN1342069A (zh) 2002-03-27
ZA200107318B (en) 2002-09-04
BR0008739A (pt) 2001-12-26
BG105807A (bg) 2002-03-29
DE60001266D1 (de) 2003-02-27
AU3283100A (en) 2000-09-28
DE60001266T2 (de) 2003-08-28
EP1158963A1 (de) 2001-12-05
ITMI990454A1 (it) 2000-09-05
PE20001547A1 (es) 2001-01-29
AU762532B2 (en) 2003-06-26
RU2248791C2 (ru) 2005-03-27
JP2002538197A (ja) 2002-11-12
CO5170438A1 (es) 2002-06-27
UA65652C2 (uk) 2004-04-15
PL196290B1 (pl) 2007-12-31
DK1158963T3 (da) 2003-04-28
SI1158963T1 (en) 2003-04-30
MXPA01008893A (es) 2002-10-23
CN1165295C (zh) 2004-09-08
ID30127A (id) 2001-11-08
NO319135B1 (no) 2005-06-20
ES2189739T3 (es) 2003-07-16
NZ513949A (en) 2003-10-31
AR029154A1 (es) 2003-06-18
SK12492001A3 (sk) 2001-12-03
PT1158963E (pt) 2003-06-30
HK1042246B (zh) 2005-06-03
KR20010102498A (ko) 2001-11-15
EE200100453A (et) 2002-12-16
NO20014301L (no) 2001-09-04
PL350232A1 (en) 2002-11-18
WO2000053162A1 (en) 2000-09-14
CZ20013186A3 (cs) 2002-02-13
TR200102566T2 (tr) 2002-01-21
GEP20033078B (en) 2003-10-27
NO20014301D0 (no) 2001-09-04
EP1158963B1 (de) 2003-01-22
HK1042246A1 (en) 2002-08-09
HRP20010650A2 (en) 2002-10-31
HUP0200243A2 (en) 2002-06-29
CA2364226A1 (en) 2000-09-14
IL145263A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
DE60043447D1 (de) Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid
NO20012636L (no) Kontrollert frigivelsesformulering som omfatter GNRH-II
ATE252386T1 (de) Galantamin-zusammensetzung mit gesteuerter freisetzung
DE60041124D1 (de) Ruktur mit kontrollierten eigenspannungen
ID28232A (id) Formulasi farmasi dengan pelepasan terkontrol
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
ATE277111T1 (de) Farbstabile superabsorbierende polymerzusammensetzung
DE69829254D1 (de) Arzneistoffzubereitung mit kontrollierter Wirkstofffreisetzungsrate
FI990170A0 (fi) Maksunosoitus
PT1086701E (pt) Composicao laxante contendo simeticone
NO20002126D0 (no) Formulering med forlenget frigjøring
NO20001375L (no) Legemiddelformulering med kontrollert virkestoffrigivning
DE60009106D1 (de) Mikrokapseln mit veränderlicher freisetzung
DE60027274D1 (de) Mikroporöser film
ATE231392T1 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
NO20020873L (no) Omfestbar absorberende artikkel
DE60045012D1 (de) Filmbildende zusammensetzung mit oktylbenzoat
DE69821977D1 (de) Flüssige, insektizide aufgiessformulierung
ATE281076T1 (de) Flüssige herbizidzusammensetzung
DE60025760D1 (de) Anisotrop-leitender film
DE60028890D1 (de) Flüssigkeitserhitzer
DE19983627T1 (de) Knoblauch-Formulierungen mit kontrollierter Freisetzung
ATE250092T1 (de) Polyolformulierung
DE69717773D1 (de) Pestizidformulierung mit kontrollierter Freisetzung
DE60004025D1 (de) Flüssiges deodorant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1158963

Country of ref document: EP

REN Ceased due to non-payment of the annual fee